Tactical Wealth: From Military to Money

In this episode, former Navy SEAL and host Kaj Larsen sits down with Dr. Brenden Borrowman, a decorated Army veteran turned neuroscience entrepreneur. After surviving a complex ambush in Afghanistan that left him with a traumatic brain injury, Dr. Borrowman refused to accept the limits placed on him. Instead, he turned his pain into purpose, launching NeuroLabs, a cutting-edge neurotech company transforming how we treat brain trauma, PTSD, and performance optimization.

From combat zones to clinical trials, Dr. Borrowman shares the unfiltered truth about transitioning out of the military, battling invisible wounds, and building a startup on a mission to save lives.

You’ll hear:

✅ Why entrepreneurship feels like a 360° firefight

✅ The science behind PTSD and brain injury recovery

✅ How to go from GED to PhD

✅ Lessons in fundraising, leadership, and grit

✅ What every veteran should know before launching a business

Whether you’re a veteran looking for your next mission, an entrepreneur seeking purpose, or someone passionate about brain health and innovation, this episode is filled with heart, hustle, and hard-earned wisdom.

👉 Ready to turn adversity into action? Hit subscribe and let’s get tactical.

🔔 Don’t forget to like, comment, and ring the bell so you never miss a mission.

EPISODE RESOURCES:

Instagram: @brenden_grizz

LinkedIn: Brenden Borrowman PhD

Instagram: @KajLarsen

LinkedIn: Kaj Larsen

www.siebert.com/valor

--
Tactical Wealth is a Gebbia Media production, brought to you by Siebert.Valor, a military-focused initiative from Siebert Financial. The Tactical Wealth podcast is for informational and entertainment purposes only. The views expressed by guests are their own and do not necessarily reflect those of Siebert Financial. This podcast does not constitute investment advice, an offer to sell, or a solicitation to buy any securities. Past performance is not indicative of future results. Listeners should consult a qualified financial professional before making any investment decisions.
For more information and disclosures, please visit siebert.com/disclosures.